Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
ATOX1_HUMAN
Entity type
UniProt
Source
Source Link
Details
Accession
O00244
EntryName
ATOX1_HUMAN
FullName
Copper transport protein ATOX1
TaxID
9606
Evidence
evidence at protein level
Length
68
SequenceStatus
complete
DateCreated
2000-05-30
DateModified
2021-06-02
Ontological Relatives
Genes
ATOX1
GO terms
Show/Hide Table
GO
Name
GO:0005507
copper ion binding
GO:0005829
cytosol
GO:0006825
copper ion transport
GO:0006878
cellular copper ion homeostasis
GO:0006979
response to oxidative stress
GO:0016530
metallochaperone activity
GO:0016531
copper chaperone activity
GO:0032767
copper-dependent protein binding
GO:1903136
cuprous ion binding
Subcellular Location
Show/Hide Table
Domains
Show/Hide Table
Domain
Name
Category
Type
IPR006121
Heavy metal-associated domain, HMA
Domain
Domain
IPR017969
Heavy-metal-associated, conserved site
Site
Conserved site
IPR036163
Heavy metal-associated domain superfamily
Family
Homologous superfamily
Diseases
Show/Hide Table
Drugs
Show/Hide Table
Drug
Name
Source
Type
DB00515
Cisplatin
Drugbank
small molecule
DB02772
Sucrose
Drugbank
small molecule
DB03127
Benzamidine
Drugbank
small molecule
DB09130
Copper
Drugbank
small molecule
Interactions
11 interactions
Interactor
Partner
Sources
Publications
Link
ATOX1_HUMAN
CF410_HUMAN
BioGRID, IntAct
25416956
details
ATOX1_HUMAN
GGPPS_HUMAN
BioGRID, IntAct
25416956
details
ATOX1_HUMAN
F118A_HUMAN
BioGRID, IntAct
25416956
32296183
details
ATOX1_HUMAN
ATP7B_HUMAN
BioGRID, HPRD, IntAct
10497213
10557326
12763797
12968035
16573520
17919502
details
ATOX1_HUMAN
COMP_HUMAN
BioGRID, IntAct
32296183
details
ATOX1_HUMAN
NECA1_HUMAN
BioGRID, IntAct
32296183
details
ATOX1_HUMAN
ATP7A_HUMAN
BioGRID, HPRD, matrixdb
10497213
10557326
12679332
31932435
details
ATOX1_HUMAN
TRAF4_HUMAN
BioGRID
31553645
details
ATOX1_HUMAN
FKBP4_HUMAN
HPRD
15133031
details
ATOX1_HUMAN
LYOX_HUMAN
matrixdb
31932435
details
ATOX1_HUMAN
ATOX1_HUMAN
HPRD
10966647
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree